Max Healthcare Institute Ltd. Allots Shares Under Employee Stock Option Scheme

Max Healthcare Institute Ltd. Allots Shares Under Employee Stock Option Scheme

Max Healthcare Institute Ltd. Allots Shares Under Employee Stock Option Scheme​

Max Healthcare Institute Limited announced the allotment of 57,461 equity shares on April 1, 2026, following the exercise of vested stock options under the Max Healthcare Institute Limited - Employee Stock Option Scheme 2022. The Nomination & Remuneration Committee approved the allotment. Each share has a face value of ₹10.

The allotment increases the company’s paid-up equity share capital from ₹973,13,50,410 to ₹973,19,25,020, and the number of equity shares from 97,31,35,041 to 97,31,92,502.

Details of the allotment are as follows:

ParticularsDetails
Company Name & AddressMax Healthcare Institute Limited, 401, 4th Floor, Man Excellenza, S. V. Road, Vile Parle (West), Mumbai - 400 056
Stock Exchanges Listed OnBSE Limited and National Stock Exchange of India Limited
Filing Date (Regulation 10(b))September 29, 2022
Filing NumbersBSE: DCS/IPO/MJ/ESOP-IP/2511/2022-23 NSE: NSE/LIST/32765
Scheme TitleMax Healthcare Institute Limited - Employee Stock Option Scheme 2022
Security TypeEquity Shares
Par Value₹ 10 per equity share
Allotment DateApril 1, 2026
Number of Shares Allotted57,461 equity shares
Distinctive Numbers97,31,35,042 to 97,31,92,502 (Both inclusive)
ISIN NumberINE027H01010
Exercise Price₹ 350 per equity share
Premium₹ 340 per equity share
Total Issued Shares97,31,92,502 equity shares
Total Issued Capital₹ 973,19,25,020
Lock-in DetailsNot Applicable
Identical to Existing SharesYes

The company noted that the allotment is not material under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Back
Top